The pancreas in familial adenomatous polyposis

Journal of the Pancreas

Volumn 9, Issue 1, 2008, Pages 9-18

  Elkharwily, Alaa ^a   Gottlieb, Klaus ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE   (United States)

Author keywords

Adenomatous polyposis coli; Gardner syndrome; Pancreatic diseases; Pancreatic neoplasms

Indexed keywords

APC PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; K RAS PROTEIN;

ADENOMATOUS POLYP; CANCER INHIBITION; CANCER RISK; COLON RESECTION; COLORECTAL CANCER; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC POLYPECTOMY; FAMILIAL ADENOMATOUS POLYP; GARDNER SYNDROME; GENE FUNCTION; GENE MUTATION; GENETIC LINKAGE; HUMAN; INDIVIDUALIZATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREAS CANCER; PANCREAS TUMOR; PANCREATITIS; REVIEW; VATER PAPILLA CARCINOMA; VATER PAPILLA TUMOR;

ADENOMATOUS POLYPOSIS COLI; AMPULLA OF VATER; COLONIC NEOPLASMS; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; RISK FACTORS;

EID: 38349172344     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Nichols RW. Desmoid tumors. A report of thirty-one cases. Arch Surg 1923; 7:227-36.
2. Gardner EJ. Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. Am J Hum Genet 1962; 14:376-90.
3. Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomateus polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001; 16:63-75.
4. Ionescu. D, Monzon F, Papachristou G, Schoen R, Weck K, Finkelstein S. Final diagnosis: familial adenomatous polyposis. University of Pittsburgh School of Medicine, Department of Pathology web site. February 2003.
5. Wijn MA, Keller JJ, Giardiello FM, Brand HS. Oral and maxillofacial manifestations of familial adenomatous polyposis. Oral Dis 2007; 13:360-5.
6. Dobbie Z, Spycher M, Mary JL, Häner M, Guldenschuh I, Hürliman R, et al. Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J Med Genet 1996; 33:274-80.
7. Bisgaard ML, Bülow S. Familial adenomatous polyposis (FAP): Genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A 2006; 140:200-4.
8. Bussey H JR. Familial polyposis coli. Family studies, histopathology, differential diagnosis and results of treatment. Baltimore: Johns Hopkins University Press. 1975.
9. Bülow S, Faurschou Nielsen T, Bülow C, Bisgaard ML, Karlsen L, Moesgaard F. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis 1996; 11:88-91.
10. Howe JR, Klimstra DS, Cordon-Cardo C, Paty PB, Park PY, Brennan MF. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res 1997; 3:129-33.
11. Perrone G, Santini D, Zagami M, Vincenzi B, Verzi A, Morini S, et al. COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters. Virchows Arch 2006; 449:334-40.
12. Fischer HP, Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004; 11:301-9.
13. Roberts RH, Krige JE, Bornman PC, Terblanche J. Pancreaticoduodenectomy of ampullary carcinoma. Am Surg 1999; 65:1043-8.
14. Park SH, Kim YI, Park YH, Kim SW, Kim KW, Kim YT, Kim WH. Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater. World J Surg 2000; 24:54-9.
15. Park SW, Song SY, Chung JB, Lee SK, Moon YM, Kang JK, Park IS. Endoscopic snare resection for tumors of the ampulla of Vater. Yonsei Med J 2000; 41:213-8.
16. Stolte M, Pscherer C. Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol 1996; 31:376-82.
17. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998; 90:1039-71.
18. Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, Hamilton SR. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992; 102:1980-2.
19. Galandiuk S, Hermann RE, Jagelman DG, Fazio VW, Sivak MV. Villous tumors of the duodenum. Ann Surg 1988; 207:234-9.
20. van Stolk R, Sivak MV Jr, Petrini JL, Petras R, Ferguson DR, Jagelman D. Endoscopic management of upper gastrointestinal polyps and periampullary lesions in familial adenomatous polyposis and Gardner's syndrome. Endoscopy 1987; 19(Suppl 1):19-22.
21. Sato T, Konishi KJ Kimura H, Maeda K, Yabushita K, Tsuji M, Miwa A. Adenoma and tiny carcinoma in adenoma of the papilla of Vater-p53 and PCNA. Hepatogastroenterology 1909, 46:1159-62.
22. Shapiro PF, Lifvendahl RA. Tumors of extrahepatic bile ducts. Ann Surg 1931; 94:61-79.
23. Baker HL, Caldwell DW. Lesions of the ampulla of Vater. Surgery 1947; 21:523-31.
24. Perzin KH, Bridge MF. Adenomas of the small intestine: A clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer 1981; 48:799-819.
25. Mizumoto I, Ogawa Y, Niiyama H, Nagai E, Sato I, Urashima T, et al. Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis. Am J Gastroenterol 2001; 96:1261-5.
26. Sanabria JR, Croxford R, Berk TC, Cohen Z, Bapat BV, Gallinger S. Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. Am J Surg 1996; 171:136-41.
27. Pauli RM, Pauli ME, Hall JG. Gardner syndrome and periampullary malignancy. Am J Med Genet 1980; 6:205-19.
28. Quirk DM, Rattner DW, Fernandez-del Castillo C, Warshaw AL, Brugge WR. The use of endoscopic ultrasonography to reduce the cost of treating ampullary tumors. Gastrointest Endosc 1997; 46:334-7.
29. Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial polyposis. Lancet 1988; 1: 1149-51.
30. Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 1993; 217:101-8.
31. Talamini MA, Moesinger RC, Pitt HA, Sohn TA, Hruban RH, Lillemoe KD, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997, 225:590-9.
32. Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, Verbeek PC, de Wit LT, Gouma DJ. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery 1995; 117:247-53.
33. Maire F, Hammel P, Terris B, Olschwang S, O'Toole D, Sauvanet A, et al. Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut 2002; 51:446-9.
34. Chetty R, Salahshor S, Bapat B, Berk T, Croitoru M, Gallinger S. Intraductal. papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. J Clin Pathot 2005; 58:97-101.
35. Sudo T, Murakami Y, Uemura K, Hayashidani Y, Takesue Y, Sueda T. Development of an intraductal papillary-mucinous neoplasm of the pancreas in a patient with familial adenomatous polyposis. Pancreas 2005; 31:428-9.
36. Komorowski RA, Tresp MG, Wilson SD. Pancreaticobiliary involvement in familial polyposis coli/Gardner's syndrome. Dis Colon Rectum 1986; 29:55-8.
37. Gupta C, Mazzara PF. High-grade pancreatic intraepithelial neoplasia in a patient with familial adenomatous polyposis. Arch Pathol Lab Med 2005; 129:1398-400.
38. Flanders TY, Foulkes WD. Pancreatic adenocarcinoma: epidemiology and genetics. J Med Genet 1996; 33:889-98.
39. Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993; 34:1394-6.
40. Schneider G, Schmid RM. Genetic alterations in pancreatic carcinoma. Mol Cancer 2003; 2:15.
41. Lemoine NR, Sirivatanauksom V, Cmogorac-Jurcevic T. Molecular profile of pancreatic cancer. Imperial Cancer Research Fund and The Cancer Research Campaign (Accessed October 7, 2004. http://www.icnet.uk/axp/mphh/biomed/ lemoine.html).
42. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997; 57:2140-3.
43. DiGiuseppe JA, Hruban RH, Offerhaus GJ, Clement. MJ, van den Berg FM, Cameron JL, van Mansfeld AD. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994; 144: 889-95.
44. Seymour AB, Hruban RH, Redston M, Caldas, C, Powell SM, Kinzler KW, et al. Allelotype of pancreatic adenocarcinoma. Cancer Res 1994; 54:2761-4.
45. Schleger C, Verbeke C, Hildenbrand R, Zentgraf H, Bleyl U. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance. Mod Pathol 2002; 15:462-9.
46. Neuman WL, Wasylyshyn ML, Jacoby R, Erroi F, Angriman I, Montag A, et al. Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes Chromosomes Cancer 1991; 3:468-73.
47. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, et al. Frequent somatic mutations of the APC gone in human pancreatic cancer. Cancer Res 1992; 52:6696-8.
48. Yashima. K, Nakamori S, Murakami Y, Yamaguchi A, Hayashi K, Ishikawa O, et al. Mutations of the adenomatous polyposis coli gene in the mutation cluster region: comparison of human pancreatic and colorectal cancers. Int J Cancer 1994; 59:43-7.
49. McKie AB, Filipe MI, Lemoine NR. Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int J Cancer 1993; 55:598-603.
50. Ding SF, Habib NA, Delhanty JD, Bowles L, Greco L, Wood C, et al. Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas. Br J Cancer 1992; 65:809-12.
51. Seket B, Saurin JC, Scoazec JY, Partensky C. Pancreatic acinar cell carcinoma in a patient with familial adenomatous polyposis. Gastroenterol Clin Biol 2003; 27:818-20.
52. Stewart CJ, Imrie CW, Foulis AK. Pancreatic islet cell tumour in a patient with familial adenomatous polyposis. J Clin Pathol 1994; 47:860-1.
53. Abraham SC, Wu TT, Klimstra DS, Finn LS, Lee JH, Yeo CJ, et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol 2001; 159:1619-27.
54. Pho LN, Coffin CM, Burt RW. Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion. Fam Cancer 2005; 4:135-8.
55. Azzarelli A, Gronchi A, Bertulli R, Tesoro JD, Baratti D, Pennacchioli E, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001; 92:1259-64.
56. Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999; 86:1185-9.
57. Heiskanen I, Järvinen HJ. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996; 11:157-62.
58. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV, et al. Desmoid turnours in familial adenomatous polyposis. Gut 1994; 35:377-81.
59. Scott RJ, Froggatt NJ, Trembath RC, Evans DG, Hodgson SV, Maher ER. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet 1996; 5:1921-4.
60. Eccles DM, van der Luijt R, Breukel C, Bullman H, Bunyan D, Fisher A, et al. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 1996; 59:1193-201.
61. Middleton SB, Frayling IM, Phillips RK. Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 2000; 82:827-32.
62. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998; 153:709-14.
63. Giarola M, Wells D, Mondini P, Pilotti S, Sala P, Azzarelli A, et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 1998; 78:582-7.
64. Bruce JM, Bradley EL 3rd, Satchidanand SK. A desmoid tumor of the pancreas. Sporadic intra-abdominal desmoids revisited. Int J Pancreatol 1996; 19:197-203.
65. Camp ER, Hochwald SN, Liu C. FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor. J Surg Oncol 2004; 87:187-90.
66. Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc 2002; 56:S226-30.
67. Sener SF, Miller HH, DeCosse JJ. The spectrum of polyposis. Surg Gynecol Obstet 1984; 159:525-32.
68. van Esch AA, Drenth JP, te Morsche RH, Jansen JB, Nagengast FM. Recurrent idiopathic pancreatitis in familial adenomatous polyposis: report of a case-series and review of the literature. Fam Cancer 2007; 6:275-80.
69. Gallagher MC, Phillips RK, Bulow S. Surveillance and management of upper gastrointestinal disease in familial adenomatous polyposis. Fam Cancm 2006; 5:263-73.
70. Heiskanen I, Kellokumpu I, Järvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999; 31:412-6.
71. Attard TM, Cuffari C, Tajouri T, Stoner JA, Eisenberg MT, Yardley JH, et al. Multicenter experience with upper Gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol 2004; 99:681-6.
72. Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63:570-80.
73. Norton ID, Geller A, Petersen BT, Sorbi D, Gostout CJ. Endoscopic surveillance and ablative therapy for periampullary adenomas. Am J Gastroenterol 2001; 96:101-6.
74. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2:783-5.